These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 7316635)

  • 21. Cell-based fluorescence assay for evaluation of new-drugs potential for phospholipidosis in an early stage of drug development.
    Fujimura H; Dekura E; Kurabe M; Shimazu N; Koitabashi M; Toriumi W
    Exp Toxicol Pathol; 2007 Aug; 58(6):375-82. PubMed ID: 17408938
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Urinary metabolic fingerprinting for amiodarone-induced phospholipidosis in rats using FT-ICR MS.
    Hasegawa M; Takenaka S; Kuwamura M; Yamate J; Tsuyama S
    Exp Toxicol Pathol; 2007 Oct; 59(2):115-20. PubMed ID: 17719757
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug-induced generalized phospholipidosis.
    Shikata T; Kanetaka T; Endo Y; Nagashima K
    Acta Pathol Jpn; 1972 Aug; 22(3):517-31. PubMed ID: 4678598
    [No Abstract]   [Full Text] [Related]  

  • 24. Rapid pulmonary phospholipid accumulation induced by intravenous amiodarone.
    Lapinsky SE; Mullen JB; Balter MS
    Can J Cardiol; 1993 May; 9(4):322-4. PubMed ID: 8513425
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A clinical flow cytometric biomarker strategy: validation of peripheral leukocyte phospholipidosis using Nile red.
    Halstead BW; Zwickl CM; Morgan RE; Monteith DK; Thomas CE; Bowers RK; Berridge BR
    J Appl Toxicol; 2006; 26(2):169-77. PubMed ID: 16278808
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical and experimental studies on phospholipidosis caused by diethylaminoethoxyhexestrol(DH)].
    Tsujii T; Matsumori T; Takahashi M; Sugioka T; Matsui T
    Saishin Igaku; 1971 Nov; 26(11):2242-50. PubMed ID: 5141966
    [No Abstract]   [Full Text] [Related]  

  • 27. Drug-induced lipidosis in human cases and in animal experiments. Accumulation of an acidic glycerophospholipid.
    Yamamoto A; Adachi S; Kitani T; Shinji Y; Seki K
    J Biochem; 1971 Mar; 69(3):613-5. PubMed ID: 5551653
    [No Abstract]   [Full Text] [Related]  

  • 28. Drug-induced phospholipidosis is caused by blockade of mannose 6-phosphate receptor-mediated targeting of lysosomal enzymes.
    Ikeda K; Hirayama M; Hirota Y; Asa E; Seki J; Tanaka Y
    Biochem Biophys Res Commun; 2008 Dec; 377(1):268-74. PubMed ID: 18840403
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improved toxicogenomic screening for drug-induced phospholipidosis using a multiplexed quantitative gene expression ArrayPlate assay.
    Sawada H; Taniguchi K; Takami K
    Toxicol In Vitro; 2006 Dec; 20(8):1506-13. PubMed ID: 16919414
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A 96-well flow cytometric screening assay for detecting in vitro phospholipidosis-induction in the drug discovery phase.
    Natalie M; Margino S; Erik H; Annelieke P; Geert V; Philippe V
    Toxicol In Vitro; 2009 Mar; 23(2):217-26. PubMed ID: 19101623
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Phospholipidosis caused by diethylaminoethoxyhexestrol].
    Matsuda Y; Ikegami F; Kobayashi K; Hasumura Y; Takada A
    Saishin Igaku; 1971 Nov; 26(11):2263-7. PubMed ID: 5141969
    [No Abstract]   [Full Text] [Related]  

  • 32. Myopathy related to administration of a cationic amphiphilic drug and the use of multidose drug distribution analysis to predict its occurrence.
    Vonderfecht SL; Stone ML; Eversole RR; Yancey MF; Schuette MR; Duncan BA; Ware JA
    Toxicol Pathol; 2004; 32(3):318-25. PubMed ID: 15204973
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Histochemical study on the pathogenesis of chlorocyclizine-induced pulmonary lipidosis.
    Gaton E; Wolman M
    Histochemistry; 1979 Sep; 63(2):203-7. PubMed ID: 40926
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Validation of an in vitro screen for phospholipidosis using a high-content biology platform.
    Morelli JK; Buehrle M; Pognan F; Barone LR; Fieles W; Ciaccio PJ
    Cell Biol Toxicol; 2006 Jan; 22(1):15-27. PubMed ID: 16463016
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Isolation & characterization of lamellar bodies from rat lung.
    Gupta RP; Murti VV; Venkitasubramanian TA
    Indian J Biochem Biophys; 1982 Jun; 19(3):175-9. PubMed ID: 7173956
    [No Abstract]   [Full Text] [Related]  

  • 36. Gene expression profiling in rat liver treated with compounds inducing phospholipidosis.
    Hirode M; Ono A; Miyagishima T; Nagao T; Ohno Y; Urushidani T
    Toxicol Appl Pharmacol; 2008 Jun; 229(3):290-9. PubMed ID: 18355885
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Proceedings: Cell changes resembling lipidosis in the rat following treatment with thymoleptics].
    Lüllmann-Rauch R; Reil GH; Scheid D
    Verh Dtsch Ges Pathol; 1973; 57():425. PubMed ID: 4142265
    [No Abstract]   [Full Text] [Related]  

  • 38. The phospholipidosis-lnducing potential of the chemopotentiating drug, N,N-Diethyl-2-[4-(phenylmethyl)phenoxy]ethanamine (DPPE, tesmilifene) correlates with its stimulation of phosphatidylserine synthesis and exposure on the plasma membrane in MCF-7 breast cancer cells.
    Xu FY; Queen G; Brandes L; Hatch GM
    Proc West Pharmacol Soc; 2007; 50():61-3. PubMed ID: 18605231
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of gentamicin-induced nephrotoxicity by lithium in rat.
    Samadian T; Dehpour AR; Amini S; Nouhnejad P
    Histol Histopathol; 1993 Jan; 8(1):139-47. PubMed ID: 8443425
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Iatrogenic phospholipidosis mimicking Fabry disease.
    Bracamonte ER; Kowalewska J; Starr J; Gitomer J; Alpers CE
    Am J Kidney Dis; 2006 Nov; 48(5):844-50. PubMed ID: 17060007
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.